Infectious Diseases – News and Features

This article explores how understanding the brain–immune ecosystem brings insights to the molecular mechanisms behind brain aging, facilitating research into immunotherapies for neurodegenerative diseases.

Stanford researchers show personalized prehab coaching improves fitness, cognition and immune resilience before surgery while reducing complications.

Researchers show doxycycline, paired with standard TB drugs, improves survival and reduces brain damage in preclinical CNS-TB models.

Researchers have identified a new subtype of lymphoma which could pave the way to improved and more targeted treatments for some blood cancer patients.

Scientists have discovered that disturbing the manganese balance in Borrelia burgdorferi weakens its defences, opening opportunities for new Lyme disease treatments.

A new study, published in Nature, reveals a conserved genetic region that preserves species history through waves of gene flow and may be crucial to the development of some common X-linked diseases.

Researchers at the University of Kansas have discovered a human gene, the protein PARP14, plays a role in regulating interferon, part of the body’s innate immune system.

Researchers created eco-friendly cerium oxide nanoparticles loaded with the antiviral drug cidofovir, boosting its ability to kill breast cancer cells. The nanocompound outperformed the drug alone and showed strong DNA and RNA binding.

Recent studies in mice revealed that some stem cells do not replenish all blood cell lineages. Researchers from the Karolinska Institute have now explored this phenomenon in humans.

A high-precision sequencing study reveals how Epstein–Barr virus transforms B cells into inflammatory drivers that spark the widespread immune attacks seen in lupus.